Study: CPAP Reduces Risk Of Death In People With OSA
New meta-analysis demonstrates that CPAP therapy significantly reduces the risk of death for people with obstructive sleep apnea (OSA).
Resmed Unveils Unified Brand
Resmed recently introduced a comprehensive brand evolution designed to unify its brand portfolio.
Working With Sleep Labs
If at least some patients are covered by Medicare, suppliers need to be aware of the federal laws.
Second Quarter Revenue Up For Medtrade Exhibitor ResMed
ResMed revenue for the quarter ended Dec. 31, 2024 increased 10% to $1.3 billion; up 10%.
CPAP Payment Prohibition
The purpose is to ensure that the CPAP device is medically necessary by preventing the CPAP supplier’s financial interest from creeping into the diagnosis and treatment.
Revenue Up At Medtrade Exhibitor ResMed
Results for the first quarter of fiscal year 2025 at ResMed are in with revenue up by 11% to $1.2 billion.